Literature DB >> 16458277

Synthesis of octa- and dodecamers of D-ribitol-1-phosphate and their protein conjugates.

Anikó Fekete1, Peter Hoogerhout, Gijsbert Zomer, Joanna Kubler-Kielb, Rachel Schneerson, John B Robbins, Vince Pozsgay.   

Abstract

The bacterial cell-wall-associated teichoic acids contain predominantly D-ribitol residues interconnected by phosphodiester linkages. Because of their location, these antigens may be vaccine candidates as part of conjugate vaccines. Here, we describe the synthesis of extended oligomers of D-ribitol-1-phosphate linked to a spacer having an amino group at its terminus. The synthesis utilized a fully protected D-ribitol-phosphoramidite that was oligomerized in a stepwise fashion followed by deprotection. The free oligomers were connected to bovine serum albumin using oxime chemistry. Thus, the ribitol phosphate oligomers were converted into keto derivatives, and the albumin counterpart was decorated with aminooxy groups. Reaction of the functionalized saccharide and protein moieties afforded conjugates having up to 20 ribitol phosphate chains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458277     DOI: 10.1016/j.carres.2005.10.023

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  7 in total

1.  Synthesis of an experimental glycolipoprotein vaccine against Lyme disease.

Authors:  Vince Pozsgay; Joanna Kubler-Kielb
Journal:  Carbohydr Res       Date:  2006-11-17       Impact factor: 2.104

2.  Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera.

Authors:  Daniel S Schmidt; Kathryn T Bieging; Patricia Gomez-de-León; Alberto Villaseñor-Sierra; Jaime Inostroza; John B Robbins; Rachel Schneerson; George M Carlone; Sandra Romero-Steiner
Journal:  Pediatr Infect Dis J       Date:  2012-08       Impact factor: 2.129

3.  Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice.

Authors:  Vince Pozsgay; Joanna Kubler-Kielb; Rachel Schneerson; John B Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

4.  Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.

Authors:  G Ravi; Yeldur P Venkatesh
Journal:  Glycoconj J       Date:  2014-08-10       Impact factor: 2.916

5.  Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Authors:  Eli B Nix; Kylie Williams; Andrew D Cox; Frank St Michael; Sandra Romero-Steiner; Daniel S Schmidt; William G McCready; Marina Ulanova
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

6.  Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.

Authors:  Angjelina Konini; Eli Nix; Marina Ulanova; Seyed M Moghadas
Journal:  Prev Med Rep       Date:  2016-01-26

7.  Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.

Authors:  Nadia A Charania; Seyed M Moghadas
Journal:  BMC Public Health       Date:  2017-09-13       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.